Pseudomonas aeruginosa global clones associated with multidrug-resistant (MDR) and
extensively drug-resistant (XDR) phenotypes, denominated high-risk clones, are a growing …

P. aeruginosa is classified as a priority one pathogen by the World Health Organisation, and
new drugs are urgently needed, due to the emergence of multidrug-resistant (MDR) strains …

Carbapenem-resistant Pseudomonas aeruginosa is one of the major concerns in clinical
settings impelling a great challenge to antimicrobial therapy for patients with infections …

Introduction Carbapenemases are β-lactamases able to hydrolyze a wide range of β-lactam
antibiotics, including carbapenems. Carbapenemase production in Enterobacterales …

Pseudomonas aeruginosa high-risk clones are disseminated worldwide and they are
common causative agents of hospital-acquired infections. In this review, we will summarize …

The dissemination of bla KPC-harboring Pseudomonas aeruginosa (KPC-Pa) is considered
a serious public health problem. This study provides an overview of the epidemiology of …

Carbapenem-resistant P. aeruginosa has become a major clinical problem due to limited
treatment options. However, studies assessing the trends in the molecular epidemiology and …

Pseudomonas aeruginosa is an opportunistic Gram-negative pathogen with an increase in
the frequency of infections caused by multidrug resistant (MDR) and extensively drug …

Pseudomonas aeruginosa is the most common bacterium occurred in nosocomial infections
and is also an important indicator of food spoilage. The worldwide spread of multidrug …

This nationwide study aimed to investigate the molecular characteristics of metallo-β-
lactamase (MBL)-producing Pseudomonas aeruginosa in Serbia, underlying resistance …